Form 4: SeaStar Medical Director Jennifer Baird Boosts Stake Through RSU Vesting and Open Market Purchase
Insider Transaction Report
SeaStar Medical Holding Corp. Director Jennifer A. Baird increased her beneficial ownership of common stock through the vesting of restricted stock units and an open market purchase in June 2025.
Summary
- Jennifer A. Baird, a Director of SeaStar Medical Holding Corp. (ICU), reported changes in her beneficial ownership of common stock.
- On June 4, 2025, 2,667 restricted stock units (RSUs) vested and converted into shares of ICU common stock. These RSUs were part of an 8,000 RSU grant on November 13, 2024, vesting in three approximately equal annual installments on the first, second, and third anniversaries of June 4, 2024.
- Following the RSU vesting, beneficial ownership of common stock was 18,000 shares.
- On June 30, 2025, Jennifer A. Baird purchased 10,000 shares of common stock in an open market transaction at a price of $0.4174 per share.
- After these transactions, total beneficial ownership of common stock increased to 28,000 shares, which includes 5,333 shares underlying unvested RSUs previously reported in Table II and now moved to Table I for reporting purposes.
Sentiment
Score: 7
Explanation: The sentiment is positive due to a director's open market purchase of shares, indicating confidence in the company. The RSU vesting is a neutral event but contributes to increased insider ownership.
Positives
- A director, Jennifer A. Baird, increased her direct ownership in SeaStar Medical Holding Corp. through an open market purchase of 10,000 shares at $0.4174 per share, signaling confidence.
- The vesting of 2,667 restricted stock units indicates the fulfillment of compensation agreements and conversion into direct equity, increasing insider alignment.
Future Outlook
No forward-looking statements or guidance are provided in this insider transaction report.
Industry Context
This Form 4 filing details an insider transaction, specifically a director's increase in share ownership. While not directly related to broader industry trends, insider buying can be interpreted by the market as a signal of management's confidence in the company's future performance within its industry.
Stakeholder Impact
- Shareholders: Increased insider ownership may be viewed positively, signaling management's belief in the company's value and potentially boosting investor confidence.
Key Dates
| Date | Description |
|---|---|
| 2024-06-04 | First anniversary of RSU vesting schedule for 8,000 RSUs granted on November 13, 2024. |
| 2024-11-13 | Date 8,000 Restricted Stock Units (RSUs) were granted to the reporting person. |
| 2025-06-04 | Date of vesting and conversion of 2,667 Restricted Stock Units into common stock. |
| 2025-06-30 | Date of open market purchase of 10,000 shares of common stock. |
| 2025-07-02 | Date the Form 4 was signed by David Green, as attorney-in-fact. |
Recommendation
holdKeywords
SeaStar Medical Holding Corp, ICU, Form 4, Insider Trading, Jennifer A. Baird, Director, Stock Purchase, Restricted Stock Units, RSU Vesting, Beneficial Ownership, Equity, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.